The Effect of Lung-Conduction Exercise in Chronic Obstructive Pulmonary Disease (COPD): Randomized, Assessor-blind, Multicenter Pilot Trial

Not Applicable

Recruiting

• Conditions: Diseases of th respiratory system

• Registration Number: KCT0004724
• Lead Sponsor: Dunsan Korean Medicine Hospital of Daejeon University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Moderate and severe COPD patients who diagnosed by forced expiratory volume in 1 second (FEV1) / forced vital capacity (FVC) <70 % and 30 % = FEV1 <80 %, aged 40 to 80, had complaints of difficulty in breathing at or above mMRC =2 points, voluntarily agreed to participate in this clinical trial is included.

Exclusion Criteria

Have serious respiratory illnesses other than COPD (e.g. lung cancer, pneumonia, active tuberculosis, tuberculosis pulmonary destruction, pneumonectomy, etc.); or with unstable cardiovascular disease (unstable angina, acute myocardial infarction, severe aortic stenosis, etc.) and severe untreated pulmonary hypertension; or with a history of acute deterioration within 2 weeks; or have a change in FEV1 or FVC of 12 % and 200 mL or more for 1 second before or after bronchodilator and attack of asthma; or with other illnesses that may cause death or disability during one year period (e.g. cancer, heart failure, coronary artery disease, cerebrovascular disease, kidney failure, diabetes with severe complications, uncontrolled high blood pressure, etc.); or have difficulty in walking (e.g., cerebrovascular disease, osteoarthritis, and other serious malnutrition); or persons who are unable to understand the consent form or continue the test due to mental retardation or intellectual problems; or pregnant or lactating women; or alcoholics or those with a history of substance abuse; or smoker; or participants who took medication of other clinical trials within 30 days prior to participation in this trial (based on written consent); or with a underlying disease judged by the investigators to be inappropriate for this trial.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
6-minute walk distance (6MWD)

Secondary Outcome Measures

Name	Time	Method
Pulmonary function test (FEV1, FVC, FEV1/FVC);Modified Borg scale;mMRC score (modified medical research council);CAT (COPD assessment test);SGRQ (The St. George's Respiratory Questionnaire)